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ABSTRACT
Mammalian cells express a variety of nucleic acid
sensors as one of the first lines of defense against
infection. Despite extensive progress in the study of
sensor signaling pathways during the last decade,
the detailed mechanisms remain unclear. In our
previous studies, we reported increased type I in-
terferon expression and the upregulation of sev-
eral proposed cytosolic DNA sensors after transfec-
tion of several tumor cell types with plasmid DNA
(pDNA). In the present study, we sought to reveal
the early events in the cytosolic sensing of this nu-
cleic acid in a myoblast cell line. We demonstrated
that DNA-dependent activator of interferon regula-
tory factors/Z-DNA binding protein 1 (DAI/ZBP1)
bound plasmid DNA in the cytosol within 15 minutes
of transfection and at consistent levels for 4 h. In-
terferon activated gene 204 protein (p204) and DEAH
box helicase 9 (DHX9) also bound pDNA, peaking 15
and 30 min respectively. Plasmid DNA was not de-
tectably bound by DEAD box helicase 60 (DDX60)
protein, despite a similar level of mRNA upregula-
tion to DAI/ZBP1, or by cyclic GMP-AMP synthase
(cGAS), despite its presence in the cell cytosol. Taken
together, these results indicate several DNA sensors
may participate and cooperate in the complex pro-
cess of cytosolic DNA sensing.
INTRODUCTION
The infection of mammalian cells induces the produc-
tion of type I interferon (IFN) and pro-inflammatory cy-
tokines (1,2). The central event in this process is the recogni-
tion of pathogen-associated molecular patterns by a group
of cytosolic proteins termed pattern recognition receptors
(PRRs). PRRs are expressed in a wide variety of mam-
malian cells and can be divided into several classes based on
their subcellular localization and specificity (3–6). Since the
first cytosolic DNA-specific PRR or DNA sensor, DNA-
dependent activator of IFN-regulatory factors/Z-DNA-
binding protein 1 (DAI/ZBP1), was reported to elicit a type
I IFN-mediated immune response (7), many additional cy-
tosolic DNA sensors have been proposed (6,8), suggest-
ing a redundant or cell type specific role in DNA sens-
ing (9–11). This response is initiated via the cyclic guano-
sine monophosphate (GMP)–adenosine monophosphate
(AMP) synthase-cyclic GMP-AMP synthase-stimulator of
IFN gene (cGAS-cGAMP-STING) pathway (12), although
sensors such as polyglutamine binding protein 1 (PQBP1)
(13) or interferon gamma inducible factor 16 (IFI16) (14)
complex with DNA and cGAS to promote its function. The
sophisticated interplay of apparently parallel sensing path-
ways complicates the ability to estimate the individual con-
tributions of specific DNA sensors in the response to cy-
tosolic DNA. Thus, detailed mechanisms of DNA detection
on the cellular level still remain unclear.
Viral and non-viral methods are currently used to de-
liver DNA into cells for in vitro and in vivo purposes. Viral
methods are effective; however, viruses by their nature bind
and activate DNA sensors (9,15). Non-viral approaches to
DNA delivery are less efficient and often require chemical
or physical assistance (16). One physical method, electropo-
ration, is widely used in laboratory applications for plasmid
DNA (pDNA) delivery (17).
Electroporation is an almost instantaneous process (18).
Plasmid DNA crosses the plasma membrane as soon as 10
min after pulse application, which makes it a valuable tech-
nique to precisely document the early events of cytosolic
DNA sensing (19–21). Several groups of proteins, including
nucleocytoplasmic shuttling proteins, motors, transcription
factors, and RNA binding proteins, bind pDNA within 15
min of delivery by electroporation (22). Cell defense pro-
*To whom correspondence should be addressed. Tel: +1 757 683 2416; Fax: +1 757 451 1010; Email: lheller@odu.edu
Correspondence may also be addressed to Maja Cemazar. Tel: +386 1 5879 544; Fax: +386 1 5879 544; Email: MCemazar@onko-i.si
C© The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License
(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work










niversity user on 02 D
ecem
ber 2019
10236 Nucleic Acids Research, 2019, Vol. 47, No. 19
teins such as DNA sensors may also bind DNA with these
kinetics.
Recent studies from our group demonstrated increased
expression of various cytosolic DNA sensors as well as type
I IFN after electroporation of control pDNA into differ-
ent tumor cell lines (23,24). These effects were cell type and
pulse protocol specific. However, these observations were
made significantly after transfection and therefore did not
reveal initial DNA sensing events. In addition, these studies
were performed on tumor cell lines, which may have dis-
torted innate immune signaling. Therefore, in this study, we
sought to reveal the specific DNA sensors reacting to the
presence of plasmid DNA introduced into non-tumor my-
oblast cells. We found that several putative DNA sensors




C2C12 murine skeletal myoblast cells (CRL-1772, Ameri-
can Type Culture Collection, Manassas, VA, USA) in their
proliferation phase were cultured as monolayers in Dul-
becco’s modified Eagle medium (DMEM, Corning, Man-
assas, VA, USA) supplemented with 5% fetal bovine serum
(FBS, Atlanta Biologicals, Flowery Branch, GA, USA) at
37◦C in 5% CO2. The cells were routinely tested for my-
coplasma infection (LONZA MycoAlert, Basel, Switzer-
land or e-myco Valid Mycoplasma PCR Detection kit, In-
tron Biotechnology, Burlington, MA, USA) and were my-
coplasma free.
Plasmids and antibodies
A plasmid encoding green fluorescent protein (GFP) driven
by the CMV-IE promoter/enhancer, gWizGFP, and gWiz-
Blank, which encodes no transgene, were commercially pre-
pared (Aldevron, Fargo, ND, USA) at a concentration of 2
g/l in physiological saline.
The primary antibodies used for pull-down experi-
ments and western blotting were rabbit mouse-reactive
anti-DAI/ZBP1 (Thermo Fisher Scientific, Waltham, MA,
USA), anti-cyclic AMP response-element binding protein
(CREB, Abcam, Cambridge, MA, USA), anti-DDX60
(Abcam), anti-cGAS (Cell Signaling Technology, Danvers,
MA, USA), anti-ifi204 (Thermo Fisher Scientific), anti-
Ku70 (Thermo Fisher Scientific), anti-DHX9 (Abcam),
anti-DEAD box helicase 41 (DDX41; Abcam) and rat
mouse-reactive anti-CD4 (eBioscience, San Diego, CA,
USA). Goat anti-rabbit IgG H&L (Alexa Fluor 680) and
goat anti-rat IgG H&L (Alexa Fluor 680) (both Thermo
Fisher Scientific) were used as secondary antibodies. For
western blotting, all antibodies were diluted in 5% skim
milk. Anti-ds DNA antibody (Abcam) and donkey anti-
mouse IgG H&L (Alexa Fluor 488) (Jackson Immunore-
search, Bar Harbor, ME, USA) were used as primary
and secondary antibodies, respectively, for the confocal
visualization of pDNA. For colocalization studies, anti-
DAI/ZBP1 (Thermo Fisher Scientific) and donkey anti-
rabbit Cy3 (Jackson Immunoresearch, Bar Harbor, ME,
USA) were used as primary and secondary antibodies.
Plasmid DNA transfection
A C2C12 cell suspension of 2.5 × 107 cells/ml in electropo-
ration buffer (23) was mixed with a 2 g/l pDNA solution
at a 4:1 ratio to a final pDNA concentration of 0.4 g/l.
The mixture was transferred either between two stainless
steel plate electrodes with 2 mm gap or into a cuvette (BTX
Harvard Apparatus, Holliston, MA, USA). Transfection
was achieved by the application of eight 5 ms pulses at a
voltage-to-distance ratio of 600 V/cm and a frequency of
1 Hz (EP1) (25) or six 100 s pulses at 1300 V/cm at fre-
quency of 4 Hz (EP2) (26). The cells were immediately trans-
ferred into the wells of a 6-well culture plate containing FBS
to ensure proper cell recovery. After 5 min of incubation,
DMEM was added and the plates were incubated at 37◦C in
5% CO2 for the time designated in each experiment. Trans-
fections were also performed using Transit LT1 (Mirus Bio
LC, Madison, WI, USA) per manufacturer’s instructions.
Transfection efficiency
Transfection efficiency was quantified 24 h after transfec-
tion as previously described (23).
Cell survival
Cell survival was quantified 6 h after transfection as previ-
ously described (23).
Confocal microscopy
Cells were seeded onto 12-well removable chamber slide
(Ibidi GmbH, Martinsried, Germany) and transfection was
performed 24 h later using EP2. After 15 min, the cells
were fixed with 4% paraformaldehyde for 15 min at 37◦C.
Cell membrane was then labelled with wheat germ agglu-
tinin (WGA) Alexa Fluor 647 (5 g/ml, Thermo Fisher
Scientific). Cells were permeabilized (10 min, 0.1% Tween),
blocked for one hour (1% BSA, 0.1% Tween 20, 22.52
mg/ml glycine) and incubated overnight at 4◦C with anti-
ds DNA antibody (Abcam), followed by incubation with
secondary antibody for one hour at room temperature. Nu-
clei were stained with Hoechst 33258 (1 g/ml, Thermo
Fisher Scientific) for 10 min. Chambers were removed and
slides were mounted using Prolong Gold Diamond An-
tifade Mountant (Thermo Fisher Scientific). Imaging was
performed with an LSM 800 confocal microscope (Carl
Zeiss, Oberkochen, Germany) with a 63× oil immersion ob-
jective and a numerical aperture of 1.4. The lasers provid-
ing excitation light at wavelength of 405, 488 and 640 nm
were used for visualization of Hoechst 33258, Alexa 488 and
Alexa 647, respectively. The emitted light was collected se-
quentially with Gallium Arsenide Phosphide (GaAsP) de-
tector via a variable dichroic at the following wavelengths:
410–617 nm (Hoechst) where additional 620 short pass fil-
ter was used, 400 – 650 nm (Alexa 488) and 645–700 nm
(Alexa 647). The collected Z-stacks were then visualized in
Imaris software (Bitplane, Zurich, Switzerland).
For colocalization studies, pDNA was stained before
transfection with Label IT Nucleic Acid Labeling Kit,
MPF488, (MIR7100, Mirus Bio, Madison, USA) accord-
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transfection, culture media was added to the wells and slides
were incubated for a total of 15 min. Cells were stained with
primary anti-DAI/ZBP1 antibody (Thermo Fisher Scien-
tific) overnight and secondary donkey anti-rabbit Cy3 an-
tibody (Jackson Immunoresearch) for one hour, otherwise
they were processed as described above with additional laser
providing excitation light at wavelength of 570 nm and emis-
sion filter 550–570 nm.
Reverse transcription real time PCR
Messenger RNAs were quantified at specific time points af-
ter transfection as previously described (23,24).
Plasmid biotinylation, DNA pull-down and slot blot
Plasmid was labeled with photobiotin acetate (Santa Cruz)
as described previously (27,28). The final concentration
of biotin-labeled gWizGFP was measured by spectropho-
tometer (NanoVue, GE Healthcare Bio-sciences, Pitts-
burgh, PA, USA) and adjusted to 2 g/L by nuclease-free
water.
After transfection, the cells were incubated for 10, 25,
55 or 235 min, then harvested by centrifugation for 5
min, creating a 15, 30, 60 or 240 min total time, re-
spectively. Cells were then quickly rinsed with PBS and
lysed (Cell Lysis Buffer, Cell Signaling Technology). Biotin-
labeled DNA was pulled down using Streptavidin Magnetic
Beads (Thermo Fisher Scientific) in accordance with man-
ufacturer instructions. After washing with TBS-Tween, the
beads were treated with DNase (Ambion DNA-free Kit,
Foster City, CA, USA) in accordance with manufacturer in-
structions. The beads were removed by centrifugation and
proteins from the supernatant were transferred to a nitrocel-
lulose membrane using a Bio-Dot SF Microfiltration Appa-
ratus (Bio-Rad) followed by a standard western blot proce-
dure.
Western blotting
For western blotting, C2C12 cells were lysed with Cell Ly-
sis Buffer (Cell Signaling Technology) to prepare whole-cell
lysate. Alternatively, nuclei were removed (Nuclei EZ Prep,
Sigma-Aldrich, St. Louis, MO, USA) from naı̈ve C2C12
cells to create cytosolic fraction. Western blotting was per-
formed as previously described (24). REVERT Total Pro-
tein Stain (LI-COR, Lincoln, NE, USA) was used for nor-
malization according to manufacturer’s instructions.
Protein pull-down and PCR to quantify bound plasmid
After transfection, the cells were incubated and lysed as
above. The lysates were pre-cleared with Protein A Agarose
beads (Cell Signaling Technology) by shaking for one hour
at 4◦C. Protein was pulled down by Protein A Agarose
Beads in accordance with manufacturer’s instructions us-
ing specific antibodies listed above. The beads were washed
three times with lysis buffer and resuspended in molecu-
lar grade water for PCR analysis. Bound gWizGFP was
quantified by PCR (CFX96 Real Time PCR Detection Sys-
tem, Bio-Rad, Hercules, CA, USA) using custom primers
(Integrated DNA Technologies, Coralville, IA, USA) to
base pairs 567–751 within the CMV-IE promoter/enhancer
region (forward 5′- ATCATATGCCAAGTACGCCC-3′,
reverse 5′- TGAGTCAAACCGCTATCCAC-3′) and base
pairs 2085–2221 within the GFP open reading frame (for-
ward 5′- CTCTGTGCTATGGTGTTCAATG-3′, reverse
5′- TGTCTTGTAGTTGCCGTCATC-3′) in SYBR Select
Master Mix (Applied Biosystems, Foster City, CA , USA).
Water was used as no template control. Absolute quan-
tification was performed by comparison to serial dilutions
of gWizGFP DNA, then relative quantification was per-
formed by comparison to control sample incubated with
anti-CD4 antibody.
siRNA silencing
For siRNA experiments, 1 × 106 cells were seeded to
10 cm Petri dishes 24 h before transfection. Commer-
cially available DHX9, DAI/ZBP1, p204 and control siR-
NAs (Silencer Select siRNA, Thermo Fischer Scientific)
were mixed with Lipofectamine RNAiMAX Transfection
Reagent (Thermo Fischer Scientific) following manufac-
turer’s instructions and added to the cells. After 48 h of in-
cubation, the cells were harvested, counted and transfected
with pDNA as described above. Values of the experimental
groups were normalized to control siRNA values.
Plasmid sequence analysis
The 5757 base pair gWizGFP sequence was analyzed us-
ing PROMO version 3 (29,30). Five CREB binding re-
gions within the CMV IE promoter/enhancer were de-
tected (base pairs 454–475, 507–516. 590–599, 776–785,
1035–1045). The non-B DB (31) was used to analyze for
Z-DNA forming sequence motifs. A single motif was de-
tected at base pairs 3756–3765. IFI16, the human or-
tholog of p204, senses dsDNA>60 base pairs long inde-
pendent of sequence. Therefore, this protein could bind
DNA throughout the plasmid (32). DHX9 binds CpG-B
DNA (33), which has the general formula purine-purine-
CG-pyrimidine-pyrimidine while lacking a poly-G motif
(34). gWizGFP contains 28 of these motifs, including 9 that
have increased immunostimulatory activity in mouse cells
(35,36).
Statistical analysis
Statistical analysis was performed (SigmaPlot, Systat Soft-
ware, Chicago, IL, USA or GraphPad Software, La Jolla,
CA, USA). The data were first tested for normality of distri-
bution with the Shapiro-Wilk test. The differences between
the experimental groups were statistically evaluated by two-
way analysis of variance followed by a Tukey–Kramer or
Dunnett’s post-test. A P-value of <0.05 was considered to
be statistically significant. A sample size (n) for each ex-
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RESULTS
Initiation of a pro-inflammatory response after plasmid trans-
fection
Our previous studies demonstrated that electropora-
tion of control plasmids into tumor cells induced pro-
inflammatory signaling in a cell line dependent manner
(23,24,37). To investigate the effect of plasmid electropora-
tion on non-tumor cells, we delivered pDNA into C2C12
mouse myoblasts using two different pulse protocols and a
chemical delivery method and measured the secretion of a
marker of this response, IFN , by ELISA (PBL Assay Sci-
ence, Piscataway, NJ, USA). Neither electroporation alone
nor addition of pDNA to the cell suspension induced a sig-
nificant difference from the control (Figure 1A). However,
after 4 h, pDNA delivery with EP1, EP2, or chemical deliv-
ery significantly (P < 0.001 and P < 0.05, respectively) in-
creased IFN  mRNA levels in comparison to the control.
Delivery with EP1 upregulated IFN  mRNA by nearly
1950-fold, significantly higher (P < 0.05) than delivery with
EP2, which induced an upregulation of more than 550-fold.
Chemical delivery induced a 46-fold upregulation of IFN 
mRNA (P < 0.01) after 4 h (Figure 1B).
IFN  protein was coordinately significantly (P < 0.001)
upregulated 4 h after pDNA delivery by both pulse proto-
cols. As with the mRNA levels, pDNA delivery with EP1
induced significantly higher levels of IFN  protein (P <
0.001) than EP2. Neither electroporation alone nor addi-
tion of pDNA to the cell suspension induced a significant
difference from the control in the level of IFN  protein
(Figure 1A).
The increase in IFN  production might be attributed to
the binding and activation of endosomal or cytosolic DNA
sensors. We therefore quantified changes in the mRNA
levels for several putative DNA sensors. The mRNAs of
retinoic acid inducible gene I (RIG-I) and toll-like recep-
tor 9 (TLR9) were not detected in any group in these cells.
The mRNAs of several sensors, DEAD box polypeptide 41
(DDX41), DEAH box helicase 9 (DHX9), 70 kDa subunit
of Ku antigen (Ku70) and cGAS, were detected in the cells
but not upregulated in any group (data not shown). How-
ever, the mRNA of the DEAD box helicase 60 (DDX60)
protein was comparably upregulated after pDNA delivery
with EP1 and EP2, by ∼140-fold and 430-fold respectively.
Interestingly, pDNA delivery using EP2 induced a small
but significant 5-fold increase in the mRNA of interferon
activated gene 204 protein (p204) not observed in other
groups. Finally, the mRNA of DAI/ZBP1 was upregulated
by ∼115-fold after pDNA delivery with EP1, which was sig-
nificantly higher (P < 0.05) than the 60-fold upregulation
after delivery with EP2 (Figure 1C). Chemical delivery in-
duced an approximately 14-fold upregulation of DAI/ZBP1
mRNA (P < 0.05), an approximately 30-fold upregulation
of DDX60 mRNA (P < 0.01), and a >6-fold upregulation
of p204 mRNA (P < 0.05) after 4 h (Figure 1D). As with
IFN , protein levels 8 h after pDNA transfection were co-
ordinately upregulated 1.2-fold for DAI/ZBP1 and nearly
1.5-fold for p204, but, surprisingly, no significant upregula-
tion was detected for DDX60 (Figure 1E, F).
Variation in cytotoxicity between pulse protocols with similar
transfection efficiencies
The transfection efficiency of ∼20% of the cells was simi-
lar between the two pulse protocols (Figure 2A). Delivery
using EP1 produced a significantly higher median fluores-
cence intensity, suggesting that a greater plasmid copy num-
ber reached the nucleus and was expressed in this group.
Cell survival was also pulse protocol dependent. No sig-
nificant difference in survival was found between pulse pro-
tocols in the absence of pDNA, although the viability for
each was statistically different from the control (Figure 2B).
Plasmid DNA delivery using EP1 reduced survival to 48%
after 6 h, while pDNA delivery with EP2 maintained a 90%
cell survival. Since we were attempting to reveal the early
events of DNA sensing, we chose EP2 for our further ex-
periments as a less damaging to the cells.
Kinetics of mRNA upregulation
Several mRNAs were upregulated after transfection. PCR
or reverse transcription PCR of RNA from cells transfected
with gWizGFP was now employed to more precisely assess
the dynamic changes in the mRNA levels of the biomarker
IFN , the transgene GFP, and the upregulated DNA sen-
sors. IFN  mRNA levels increased significantly within 60
min of transfection (Figure 3A). This preceded detectable
transgene expression; an increase GFP mRNA levels was
detected after 2 h that continued up to 24 h (Figure 3B). A
significant increase in DDX60 mRNAs was detected at 2 h,
while p204 was significantly increased at 5 h after transfec-
tion. DAI/ZBP1 mRNA was significantly upregulated from
5 to 24 h (Figure 3C). Peak levels did not necessarily mir-
ror those after transfection with gWizBlank (Figure 1A, C);
we previously noted plasmid-dependent variations in DNA
sensor mRNA induction (23).
Direct detection of cytoplasmic pDNA
Previous studies demonstrated that electroporated pDNA
enters the cytosol or cytoplasm within 10 min (19–21) and
transcription factors can bind to it within 15 min (38) after
transfection. To confirm the presence of pDNA in the cy-
toplasm of C2C12 cells, we performed confocal imaging 15
min after transfection. Cells in the control group and elec-
troporated cells demonstrated basal level of staining which
could be attributed to the presence of mitochondrial DNA.
Plasmid DNA aggregates were detected extracellularly in
cells suspended in pDNA. However, increased DNA stain-
ing was detected only in the transfected cells (Figure 4),
corroborating the reports that pDNA enters the cytoplasm
within minutes of transfection (19–21). Based on these data,
we chose this time point as a starting point to test for early
DNA sensor binding events.
DNA sensor proteins present at basal conditions
A protein must be present in cytoplasm in order to bind
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Figure 1. Effects of pDNA transfection on IFN  production and expression of putative cytosolic DNA sensors. (A) IFN  mRNA levels 4 h and protein
levels 6 h after transfection using electroporation with gWizBlank normalized to control group (n = 3–10). (B) IFN  mRNA levels 4 h after transfection
using Transit (T) normalized to control group (C) (n = 6–8). (C) DDX60, DAI/ZBP1 and p204 mRNA levels 4 h after electroporation normalized to
control group (n = 3–9). (D) DDX60, DAI/ZBP1 and p204 mRNA levels 4 h after chemical transfection (T) normalized to control group (C) (n = 8). (E)
Representative western blots of DDX60, DAI/ZBP1 and p204 proteins 8 h after transfection using EP2. (F) DDX60, DAI/ZBP1 and p204 upregulation
8 h after transfection using EP2 normalized to control group (n = 3 for each protein). *P < 0.05; **P < 0.01; ***P < 0.001 statistical difference from
control group.
Figure 2. Effects of different pulse protocols on transfection efficiency and cell survival. (A) The fraction of transfected cells (blue) and median fluorescence
(green) were determined by flow cytometry 24 h after gWizGFP delivery (EP1, n = 10; EP2, n = 6). (B) Survival fraction determined by Presto Blue assay
6 h after gWizBlank delivery normalized to control group (n = 24 technical replicates, n = 2 biological replicates). *P < 0.05; ***P < 0.001 statistical
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Figure 3. Kinetics of mRNA expression. (A) IFN , (B) GFP, (C)
DAI/ZBP1, DDX60, and p204 mRNA levels at 0, 0.5, 1, 5 and 24 h after
transfection (n = 5–8). *P < 0.05; **P < 0.01 statistical difference from
time 0.
cytosolic fraction of lysates obtained from control C2C12
cells for the presence of the putative DNA sensors correlat-
ing to the mRNAs detected by RT-PCR. We also tested for
the presence of CREB, which is known to bind the CMV-
IE promoter/enhancer region (22). With the exception of
DDX41, all of these proteins were detected in the cytosol
of control cells (Supplementary Figure S1).
Protein binding to cytoplasmic pDNA after transfection
Several putative DNA sensors were detected in control
cells. It was therefore possible that these proteins func-
tioned in pDNA binding. We transfected cells with biotiny-
Figure 4. Plasmid DNA enters the cytoplasm of C2C12 cells within 15 min
of transfection. Representative confocal images from the Z-stacks demon-
strate the presence of pDNA in the cytoplasm of C2C12 cells 15 min
after electroporation with EP2. Plasmid DNA was detected using anti-
ds DNA antibody (green), while membrane structures were labeled with
WGA (red). Cell nuclei were labeled with Hoescht 33258 (blue). Scale bar
equals 5 m.
lated gWizGFP, pulled down the pDNA using streptavidin-
coated beads, and tested for the presence of CD4 (as a neg-
ative control since this protein is not present in the cyto-
plasm nor is it known to bind DNA), CREB (as a posi-
tive control), DAI/ZBP1, DDX60, p204, cGAS, DHX9 or
Ku70. Whole-cell lysate of naı̈ve C2C12 cells served as addi-
tional positive control (Figure 5A). No bands were detected
in the samples probed with anti-CD4 antibody, which sug-
gested the absence of non-specific fluorescence signal (data
not shown). Intense bands were detected at each time point
on the membranes probed against CREB, peaking at 60 min
after transfection. DDX60 and Ku70 proteins were not de-
tected in pull-downs at any tested time point, although each
of these proteins was detected in a positive control sam-
ple, indicating properly performed immunoblotting. A faint
band was visible at the four hour time point on the mem-
brane probed against cGAS protein, although this band was
not quantifiable by the software. Protein bands were de-
tected on the membrane probed against DAI/ZBP1, DHX9
and p204 at each time point (Figure 5B). DHX9 and p204
binding peaked at 30 and 15 min after transfection, respec-
tively, with the further decrease, while no significant differ-
ence in band intensity was found for DAI/ZBP1 at any time
point (Figure 5C).
We next performed protein immunoprecipitations (Fig-
ure 5D) to confirm DNA sensor binding using specific
antibodies against DAI/ZBP1, DHX9 and p204, which
were found to bind biotinylated plasmid. We also included
DDX60 and cGAS in the tested panel, since DDX60
mRNA was upregulated after transfection, and cGAS is
considered to be essential for the induction of a type I IFN
response to cytosolic DNA (39). An antibody against CD4
was applied to serve as negative control, while an antibody
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Figure 5. Protein immunoprecipitation and pDNA pull-down. (A) Schematic representation of biotinylated pDNA pull-down. (B) Representative mem-
branes demonstrating proteins’ binding to pDNA detected by western blotting. Whole-cell C2C12 lysate serves as positive control (bottom line). (C) Time
course of CREB, DAI/ZBP1, DHX9 and p204 binding to pDNA (n = 3 for each protein). All time points represent time after gWizGFP transfection. (D)
Schematic representation of protein immunoprecipitation. (E) gWizGFP plasmid copy number normalized to CD4 group (n = 3 for CREB, DHX9 and
cGAS groups, n = 6 for the other groups). No statistical difference was observed within any group whether the CMV promoter (blue) or the GFP open
reading frame (green) was targeted. *P < 0.05; **P < 0.01; ***P < 0.001 statistical difference from control group. (F) Representative confocal microscopy
images demonstrating colocalization of DAI/ZBP1 and pDNA. Nuclei were counterstained with Hoechst 33258 (blue) and membranes with WGA (red).
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munoprecipitation, bound pDNA was quantified by PCR.
Fifteen minutes after transfection, the relative amounts of
pDNA pulled down with the antibodies against cGAS and
DDX60 did not differ from the negative control, while the
antibodies against DHX9 and DAI/ZPB1 proteins pulled
down ∼8-fold more pDNA copies (Figure 5E). Surpris-
ingly, the amount of pDNA pulled down with the antibody
against p204 was not significantly different from the nega-
tive control. No difference was observed in the quantifica-
tion of the two targeted pDNA regions, implying that the
pDNA molecules were intact. Plasmid DNA colocalization
with DAI/ZBP1, which is a rare event, was confirmed by
confocal microscopy at 15 min after transfection (Figure
5F).
siRNA
The mRNA and protein upregulation coupled with the con-
firmation of direct pDNA binding implied that specific sen-
sors might play a part in the activation of the DNA sensor
pathway. We used siRNA silencing to deduce the relative
contributions of DAI/ZBP1, p204 and DHX9. Since the
levels of IFN  and DDX60 were very low in control cells,
we were unable to test these mRNAs reliably. Exposure of
C2C12 cells to control siRNA alone did not significantly
modulate any of the targets from background levels at 48 h
(data not shown). Nevertheless, expression levels were nor-
malized to control siRNA to exclude the effects of its pres-
ence in the cells.
Incubation of C2C12 cells with DAI/ZBP1, DHX9 or
p204 siRNAs led to significant downregulation of the cor-
responding mRNAs with or without pDNA transfection.
To investigate the importance of these sensors in the DNA
sensing pathway, we tested the level of IFN  mRNA after
pDNA electroporation of C2C12 cell treated with these siR-
NAs. No significant changes in IFN  expression were de-
tected after treatment the cells with control siRNAs, while
IFN  mRNA levels were downregulated after incubation
with p204 siRNA by 87%. DAI/ZBP1 or DHX9 siRNA in-
cubation did not affect IFN  mRNA levels. No siRNA
tested in this study effected the mRNA levels of cGAS or
STING after pDNA transfection (Figure 6).
DISCUSSION
Cytosolic nucleic acid sensing may be a key component
of innate immune sensing. Several proteins have been pro-
posed as cytosolic DNA sensors over the last decade, but
the detailed mechanisms of their actions have not been clar-
ified. In this study, we sought to reveal early events upon
pDNA entrance into the cell. After testing several candi-
date proteins, we identified DAI/ZBP1, p204, and DHX9
as potential early pDNA binding proteins (Figure 5). This
conclusion is based on several findings: first, the levels of
DAI/ZBP1 and p204 mRNAs and proteins were upregu-
lated after pDNA transfection; second, these proteins were
present in the cell cytoplasm at a basal level; and third, we
directly demonstrated binding of these proteins to pDNA
after transfection. Although DHX9 mRNA and protein
were not upregulated, the basal level present in the cells was
clearly adequate for the detection of pDNA binding. Taken
together, these findings allow us to hypothesize that since
these proteins bind pDNA soon after cell entry, they may
be involved in the early events in DNA sensing.
Plasmid DNA can be delivered into cells by both phys-
ical and chemical methods. Since we sought to elucidate
the immediate events after pDNA entrance into the cell, we
needed a tool that could provide fast and effective pDNA
transfection with a reliable time scale as to when the pDNA
becomes available to intracellular proteins. Works from dif-
ferent groups demonstrated that pDNA is detectable in the
cytosol or cytoplasm within 10 min of electroporation (19–
21), which gave a good reference point for our study. Fur-
thermore, this method mitigates the need for viral or chem-
ical agents that could confound the source of sensor acti-
vation. To test the applicability of electroporation for our
study, we performed confocal imaging of C2C12 cells 15
min after transfection. Transfected cells demonstrated an
increased level of staining for cytoplasmic double-strand
DNA, confirming these earlier reports.
We observed three major differences between two elec-
troporation protocols that produced similar levels of trans-
fection. First, the median fluorescence of transgene expres-
sion was significantly different (Figure 2A), implying that
EP1 delivered a greater plasmid copy number to the nu-
cleus, producing higher transgene expression. However, this
does not account for plasmids reaching the cell’s cytoplasm
but unable to achieve nuclear entry for expression. Second,
the protocols produced significant differences in cell viabil-
ity (Figure 2B). Finally, these two protocols induced signifi-
cantly different IFN  and DDX60 mRNA and protein up-
regulation (Figure 1). We previously noted that transfection
efficiency was unrelated to the upregulation of mRNAs in
this pathway (23). The protocol producing higher mRNA
and protein levels was also the protocol producing increased
cell death. Therefore, these events may be related.
These consequences of DNA electroporation may be a
reflection of the mechanism by which DNA enters the cell.
Similar to cationic lipids and polymers (40), endocytosis-
like mechanisms are necessary for transgene expression af-
ter electroporation (20,41), although pDNA may enter by
other mechanisms. After transfection, pDNA may reach
the cytosol via defective endocytosis, errors during vesicle
formation or transitions, or endosomal escape to bind and
activate cytosolic DNA sensors. These effects may vary by
cell type based on membrane composition (41), cell-specific
endocytotic pathways (42), the speed of the specific en-
docytotic pathway (43), or the level of cytosolic nucleases
(40). Variations in the parameters between protocols such
as pulse number, length, applied field may influence the ef-
ficiency of pDNA entry or of endocytotic processing.
In previous studies, we demonstrated an increase in type
I IFN and pro-inflammatory cytokine production after
pDNA delivery, indicators of DNA detection in the cytosol,
(23,24,37,44). We also observed an upregulation of several
cytosolic DNA sensing proteins. However, our studies were
conducted on various tumor cell lines, which could have im-
paired physiology as well as modulated DNA sensing mech-
anisms. Thus, we decided to clarify early cytosolic DNA
sensing events in non-tumor cells.
In the present study, the increase in IFN  production
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Figure 6. Effect of DAIZBP1, p204 and DHX9 silencing on the mRNA levels of IFN , STING and cGAS. Levels of mRNA of cytosolic DNA sensors
(DAI/ZBP1, p204 and DHX9), IFN , STING and cGAS 4 h after transfection with pDNA in cells treated for 48 h with siRNAs as noted. Levels of
mRNA were normalised to the mRNA levels in control cells treated with scrambled siRNA (n = 3 for p204 and n = 4 for DAI/ZBP1 and DHX9). ***P
< 0.001 statistical difference from the same groups in cells treated with control, scrambled siRNA.
also take place in C2C12 myoblasts. We found a dramatic
increase in the mRNA levels of DDX60 and DAI/ZBP1
and a small but significant increase in p204 mRNA af-
ter transfection. An incremental, but significant increase in
DAI/ZBP1 and p204 protein levels was also detected. De-
spite a >400-fold increase in DDX60 mRNA level after de-
livery with EP2, this upregulation was not reflected in an
increased protein level at the specific time point measured
(45). Interestingly, these were the same DNA sensors upreg-
ulated in tumor cells, although to differing extents (23,24).
We confirmed these observations using another method of
non-viral delivery, a non-liposomal formulation comprised
of a lipid and a protein/polyamine mixture (Figure 1B,
D). These results parallel previous observations of IFN 
and/or DNA sensor mRNA or protein upregulation after
liposomal DNA delivery (7,14,39,46–48) in a broad range of
cell types (4). Overall, these findings suggest the existence of
a general activation pattern in both tumor and non-tumor
cells.
Reasonably, the first step in the cascade of events that
comprise DNA sensing in the cytosol is the binding of a
sensing protein or proteins to DNA. To accomplish that, the
protein should be immediately available in the cytoplasm of
the cell. We therefore tested control cells for the presence
of proteins associated with detectable mRNAs: DAI/ZPB1,
DDX60, p204, cGAS, DHX9, Ku70 and DDX41. CREB
was included in the tested panel for its known ability to bind
pDNA (22), which made it a useful positive control for our
study. With the exception of DDX41, these proteins were
detected in the cytoplasmic fraction of C2C12 cells (Sup-
plementary Figure S1), potentially in adequate abundance
to initiate a signaling cascade culminating in IFN  mRNA
upregulation, which occurs before upregulation any of the
DNA sensors tested (Figure 3).
To determine the proteins that initially bind pDNA,
we performed pDNA pull downs from transfected cells.
Since the binding process could potentially be a dynamic
event, we tested several time points, specifically 15 min, 30
min, 1 h and 4 h after transfection. The positive control,
CREB, was bound to pDNA at each time point, compara-
ble to the results reported for CREB binding to the CMV-
IE promotor/enhancer by Dean’s group (22). Among the
tested proteins, we found that DAI/ZBP1, DHX9 and p204
bound pDNA at each time point, while we could not de-
tect DDX60 or Ku70 binding (Figure 5). Both p204 and
DHX9 demonstrated fluctuating binding levels, peaking at
15 and 30 min, respectively, with decreased binding with
time. Conversely, DAI/ZBP1 binding did not change sig-
nificantly over the tested time course.
The differences in detection levels and kinetics could
potentially be explained by the widely varying number
of putative consensus binding sites in gWizGFP for the
different proteins. Plasmid DNA sequence analysis re-
vealed five binding regions for CREB within CMV-IE
promoter/enhancer (29,30). A single Z-DNA motif (31)
might be potentially bound by DAI/ZBP1, which prefers
longer DNA such as plasmids (49). Up to 28 CpG-B motifs,
potentially bound by DHX9 (33–36) were detected, while
p204 may bind any long double stranded DNA without
sequence specificity (32). Plausibly, the single binding site
for DAI/ZBP1 may become almost immediately occupied
when the plasmid reaches the cytoplasm, while the more
abundant occupancy opportunities for CREB and DHX9
take some time to be filled. The decreasing levels of p204
and DHX9 binding may be due to binding by an unknown
protein, forming a complex that shields the antibody epi-
tope, or these proteins may be released from the plasmid
after the activation of the signaling cascade.
To confirm pDNA binding, we performed protein im-
munoprecipitations after transfection. Anti-CREB, anti-
DAI/ZBP1, and anti-DHX9 antibodies pulled down a sig-
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ing. Surprisingly, the amount of pDNA pulled down by
anti-p204 antibody did not significantly differ from the neg-
ative control. This discrepancy in p204 binding detection
between the two methods could be due to the previously
observed variations in binding affinity of p204 to pDNA
based on the salt concentration in the assay (32). Indeed,
different reagents were used in the pDNA and protein pull
down assays. Another interesting observation from the pro-
tein immunoprecipitation assay was that anti-CREB, anti-
DAI/ZBP1 and anti-DHX9 antibodies pulled down pDNA
with similar efficiency regardless of the number of putative
binding sites. With the protein immunoprecipitations, only
one pDNA copy could be pulled down no matter how many
protein-binding sites were occupied.
In addition to CREB, nearly 500 proteins were demon-
strated to bind pDNA 15 min after entry into the cytosol
(22). However, we confirmed pDNA binding for only CREB
and DHX9 (ATP-dependent RNA helicase A). The dis-
crepancies between the results of these studies could be ex-
plained by the difference in cell types, pDNA concentration,
or other experimental conditions. Badding et al. used a hu-
man tumor cell line and electroporated attached cells, while
we used a non-tumor murine cell line and electroporated
cells in suspension. Another source of discrepancy could be
formaldehyde cross-linking, which, as the authors stated,
can modify the mass of tryptic peptides, leading to misin-
terpretation of mass-spectrometry data (22).
Although cytosolic DDX60 protein was abundant in this
study, we did not detect pDNA binding by this protein.
However, the upregulation of the DDX60 mRNA 4 h af-
ter the transfection implicates its participation in the cas-
cade of events initiated by the presence of pDNA in the
cytosol. DDX60 was previously demonstrated to associate
with RIG-I protein after vesicular stomatitis virus infection,
but not in its absence (50). Hence, one could speculate that
DDX60 plays a redundant role in cytosolic DNA sensing
to ensure accurate and thorough detection of invading nu-
cleic acids. Interestingly, DHX9, which bound pDNA in our
study, belongs to the family of RIG-like helicases, support-
ing the idea of DDX60 role as an auxiliary protein in pDNA
sensing. Further studies are required to clarify the details of
DDX60 function.
DAI/ZBP1 was originally described as a tumor-
associated protein with unknown function specifically
recognizing Z-DNA (51). It was later reported as a cy-
tosolic double-strand DNA sensor activating IRF3 and
inducing type I IFN expression (7), although redundant
sensors were later described (8,13,49). Recently, several
groups (52–55) identified DAI/ZBP1 as an innate sensor
of influenza A virus and demonstrated Z-RNA binding
and colocalization with viral ribonucleoprotein complexes
formed by influenza A virus. In our study, we confirmed
DAI/ZPB1 bound pDNA by both plasmid and pro-
tein pull-down assays and by confocal microscopy after
transfection.
DHX9 is a DExD/H-box helicase that was initially
shown to play a crucial role in HIV replication (56), fur-
ther described as a central factor in replication of foot-and-
mouth disease virus (57) and influenza A virus (58). Later it
was identified as a sensor for both CpG DNA and double-
strand RNA in the cell cytoplasm (33,59) and a potentially
important protein for viral replication and anti-viral immu-
nity. We confirmed that DHX9 bound throughout the four
hour period tested, peaking at 30 min.
p204 belongs to the interferon-inducible p200 family pro-
teins, known as PYHIN or HIN-200 proteins. Initially, it
was studied for its antiproliferative role (60) and for the reg-
ulation of cell differentiation, in particular, during the dif-
ferentiation of C2C12 myoblasts into skeletal muscle type
myotubes (61). Later it was shown, together with its or-
tholog IFI16, to be the first PYHIN protein, involved in
IFN  induction, and therefore, having a role in cytoso-
lic DNA sensing (46). We demonstrated that p204 bound
pDNA, for minimally 4 h, peaking at 15 min.
Silencing experiments using siRNA implied that p204,
but not DAI/ZBP1 or DHX9, partially modulated IFN 
mRNA expression (Figure 6). This confirmed studies by
Unterholzner et al., who demonstrated that IFI16 or p204
siRNA inhibited DNA-induced IFN  (46). Silencing of
these mRNAs did not modulate cGAS or STING mRNA
levels, however. We also confirmed the interferon inducibil-
ity of DAI/ZBP1 (7) and p204 (46), which may explain the
subsequent increases in mRNA levels of these proteins (Fig-
ure 3) by a positive feedback loop.
In summary, our results indicate that DAI/ZBP1,
p204 and DHX9 directly bind cytosolic plasmid DNA af-
ter transfection. Silencing of the DNA sensor p204 mod-
ulated IFN  expression, indicating it acts as an early cy-
tosolic DNA sensor in C2C12 mouse myoblasts. However,
we were unable to demonstrate a function in DNA sensing
by DAI/ZBP1 or DHX9 in our model. This does not rule
out these proteins functioning in DNA sensing in other cell
types and other physiological conditions. Furthermore, al-
ternative DNA sensors may be required simultaneously or
at other time points to elicit the observed pro-inflammatory
response.
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